Literature DB >> 25123926

Cerebellar abnormalities in Huntington's disease: a role in motor and psychiatric impairment?

Elin M Rees1, Ruth Farmer, James H Cole, Salman Haider, Alexandra Durr, Bernhard Landwehrmeyer, Rachael I Scahill, Sarah J Tabrizi, Nicola Z Hobbs.   

Abstract

The cerebellum has received limited attention in Huntington's disease (HD), despite signs of possible cerebellar dysfunction, including motor incoordination and impaired gait, which are currently attributed to basal ganglia atrophy and disrupted fronto-striatal circuits. This study is the first to investigate a potential contribution of macro- and microstructural cerebellar damage to clinical manifestations of HD. T1- and diffusion-weighted 3T magnetic resonance imaging (MRI) scans were obtained from 12 controls and 22 early-stage HD participants. Manual delineation and voxel-based morphometry were used to assess between-group differences in cerebellar volume, and diffusion metrics were compared between groups within the cerebellar gray and white matter. Associations between these imaging measures and clinical scores were examined within the HD group. Reduced paravermal volume was detected in HD compared with controls using voxel-based morphometry (P < 0.05), but no significant volumetric differences were found using manual delineation. Diffusion abnormalities were detected in both cerebellar gray matter and white matter. Smaller cerebellar volumes, although not significantly reduced, were significantly associated with impaired gait and psychiatric morbidity and of borderline significance with pronate/supinate-hand task performance. Abnormal cerebellar diffusion was associated with increased total motor score, impaired saccade initiation, tandem walking, and timed finger tapping. In conclusion, atrophy of the paravermis, possibly encompassing the cerebellar nuclei, and microstructural abnormalities within the cerebellum may contribute to HD neuropathology. Aberrant cerebellar diffusion and reduced cerebellar volume together associate with impaired motor function and increased psychiatric symptoms in stage I HD, potentially implicating the cerebellum more centrally in HD presentation than previously recognized.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Huntington's disease; MRI; cerebellum; diffusion; imaging

Mesh:

Year:  2014        PMID: 25123926     DOI: 10.1002/mds.25984

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  Application of Quantitative Motor Assessments in Friedreich Ataxia and Evaluation of Their Relation to Clinical Measures.

Authors:  Christian Hohenfeld; Imis Dogan; Robin Schubert; Claire Didszun; Ludger Schöls; Matthis Synofzik; Ilaria A Giordano; Thomas Klockgether; Jörg B Schulz; Ralf Reilmann; Kathrin Reetz
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

2.  Morphological features in juvenile Huntington disease associated with cerebellar atrophy - magnetic resonance imaging morphometric analysis.

Authors:  Abderrahmane Hedjoudje; Gaël Nicolas; Alice Goldenberg; Catherine Vanhulle; Clémentine Dumant-Forrest; Guillaume Deverrière; Pauline Treguier; Isabelle Michelet; Lucie Guyant-Maréchal; Didier Devys; Emmanuel Gerardin; Jean-Nicolas Dacher; Pierre-Hugues Vivier
Journal:  Pediatr Radiol       Date:  2018-06-20

3.  Cerebellar Gray Matter Alterations in Huntington Disease: A Voxel-Based Morphometry Study.

Authors:  Paula C de Azevedo; Rachel P Guimarães; Camila C Piccinin; Luiza G Piovesana; Lidiane S Campos; Juliana R Zuiani; Eliza M Tamashiro; Giordanna Pinheiro; Augusto C Amato-Filho; Fernando Cendes; Iscia Lopes-Cendes; Anelyssa D'Abreu
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

Review 4.  Repeat-associated non-AUG (RAN) translation: insights from pathology.

Authors:  Monica Banez-Coronel; Laura P W Ranum
Journal:  Lab Invest       Date:  2019-03-27       Impact factor: 5.662

5.  Real-time imaging of Huntingtin aggregates diverting target search and gene transcription.

Authors:  Li Li; Hui Liu; Peng Dong; Dong Li; Wesley R Legant; Jonathan B Grimm; Luke D Lavis; Eric Betzig; Robert Tjian; Zhe Liu
Journal:  Elife       Date:  2016-08-03       Impact factor: 8.140

6.  Systems Genetic Analyses Highlight a TGFβ-FOXO3 Dependent Striatal Astrocyte Network Conserved across Species and Associated with Stress, Sleep, and Huntington's Disease.

Authors:  Joseph R Scarpa; Peng Jiang; Bojan Losic; Ben Readhead; Vance D Gao; Joel T Dudley; Martha H Vitaterna; Fred W Turek; Andrew Kasarskis
Journal:  PLoS Genet       Date:  2016-07-08       Impact factor: 5.917

7.  Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington's disease.

Authors:  Gabriel Crevier-Sorbo; Vladimir V Rymar; Raphael Crevier-Sorbo; Abbas F Sadikot
Journal:  Acta Neuropathol Commun       Date:  2020-02-07       Impact factor: 7.801

8.  Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases.

Authors:  Chiara Ticci; Daniele Orsucci; Anna Ardissone; Luca Bello; Enrico Bertini; Irene Bonato; Claudio Bruno; Valerio Carelli; Daria Diodato; Stefano Doccini; Maria Alice Donati; Claudia Dosi; Massimiliano Filosto; Chiara Fiorillo; Chiara La Morgia; Costanza Lamperti; Silvia Marchet; Diego Martinelli; Carlo Minetti; Maurizio Moggio; Tiziana Enrica Mongini; Vincenzo Montano; Isabella Moroni; Olimpia Musumeci; Elia Pancheri; Elena Pegoraro; Guido Primiano; Elena Procopio; Anna Rubegni; Roberta Scalise; Monica Sciacco; Serenella Servidei; Gabriele Siciliano; Costanza Simoncini; Deborah Tolomeo; Paola Tonin; Antonio Toscano; Flavia Tubili; Michelangelo Mancuso; Roberta Battini; Filippo Maria Santorelli
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

9.  Xeroderma pigmentosum is a definite cause of Huntington's disease-like syndrome.

Authors:  Hector Garcia-Moreno; Hiva Fassihi; Robert P E Sarkany; Julie Phukan; Thomas Warner; Alan R Lehmann; Paola Giunti
Journal:  Ann Clin Transl Neurol       Date:  2017-12-04       Impact factor: 4.511

10.  Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease.

Authors:  Jian Jing Siew; Hui-Mei Chen; Huan-Yuan Chen; Hung-Lin Chen; Chiung-Mei Chen; Bing-Wen Soong; Yih-Ru Wu; Ching-Pang Chang; Yi-Chen Chan; Chun-Hung Lin; Fu-Tong Liu; Yijuang Chern
Journal:  Nat Commun       Date:  2019-08-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.